REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
Recruiting now NCT07599904
Run by Medtronic Neurovascular Clinical Affairs · for 18 and older · All sexes
What this study is about
Post-Market Registry
Who can join (things the study team will check)
✅ You may be able to join if…
- Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
- Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device* during treatment for acute ischemic stroke.
- Participant is 18 years of age or older.
🚫 You may not be able to join if…
- Participant who may be unable to complete follow-up within the registry.
- Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
- Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.
Where this trial is running
- Buffalo General Medical Center, Buffalo, New York, United States
Who to contact
Stephanie Salisbury · 612-979-7251 · rs.recanovaregistry@medtronic.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07599904.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.